Verthermia Selects Merge eClinicalOS® for Whole Body Hyperthermia Ovarian Cancer Treatment Trial

By November 6, 2014Press Release
Merge_by_IBM_-_verthermia_cancer-treatment

Verthermia, Inc. has selected the eClinicalOS data management platform from Merge eClinical for its clinical trial exploring the potential of whole body hyperthermia as a standalone treatment for women with Stage III or IV ovarian cancer. For more information, read Merge’s press release.


Warning: count(): Parameter must be an array or an object that implements Countable in /home/verthe5/public_html/wp-includes/class-wp-comment-query.php on line 405

Leave a Reply